Under physiological conditions, interstitial fluid volume is tightly regulated by balancing microvascular filtration and lymphatic return to the central venous circulation.
INTRODUCTION
The sensitivity of tissues to an edemagenic challenge is as important as the degree of edema. Edema, the accumulation of excess interstitial fluid volume, can be both a cause and an effect (9, 12, 61) of major morbidity such as cardiac, renal and pulmonary failure. The techniques used to determine the degree of edema, however, have limited prognostic potential. For instance, different inflammatory agents such as histamine and endotoxin can result in similar degrees of edema, although edema secondary to endotoxin is more likely to worsen with increased microvascular pressure (1, 44) . Despite a focus on anti-edema mechanisms, investigators have neglected to address this sensitivity of edema formation to edemagenic challenges. Though the concept of a "gain" has been used to characterize wholebody fluid balance (30) , it has yet to be applied to interstitial fluid balance. The potential exists to bridge the gap between basic physiology and clinical practice, since the complexity of interstitial fluid balance results from three relatively simple processestransmicrovascular filtration, lymphatic return, and interstitial fluid storage. resulting from these pressure gradients is moderated by microvascular permeabilities to water and plasma proteins (46, 58) . Outflow from the interstitium, on the other hand, is determined by lymphatic vessel function and the pressure gradient from the interstitium to the central venous circulation (43) . Typically requiring an active process, the net flow depends on effective lymphatic driving pressure and effective lymphatic resistance (15) . Interstitial compliance, the change in interstitial fluid volume for a given change in interstitial fluid pressure, plays a key role in linking microvascular fluid filtration and lymphatic return. In particular, when inflow rises above outflow, interstitial compliance determines how much interstitial fluid pressure rises. Increases in interstitial hydrostatic pressure not only act to decrease flow into the interstitium, but also increase flow out via the lymphatics (48) . Even though these are relatively well-understood phenomena and their interaction is governed by conservation of mass, the resulting behavior can be exceedingly complex.
There are multiple explanations for histamine-induced pulmonary edema. The difficulty in ascribing changes in interstitial fluid volume to a particular volume-regulating phenomenon is put in bold relief by the example of histamine. Infusion of histamine induces edema within minutes (40, 52, 60) . Some reports ascribe this effect to increased transmicrovascular fluid flux due to increased permeability or vascular surface area (6, 40, 49, 56, 60) . Lymph flow is reported to increase with histamine infusion (2, 6, 10, 13, 21, 35, 49, 56, 68) either by increased contraction rate (22) or by increased strength of contraction (36, 68, 70) . However, inhibition of lymph flow with intravenous infusion of histamine at high concentrations (> 5µM) (22, 62) has also been reported, and thus the lymphatic system may play a role. Yet another mechanism for edema formation has been postulated that does not require changes in permeability or lymphatic function. Histamine has been reported to increase interstitial compliance (2, 65) . That is, given the same interstitial fluid pressure, the interstitium can accommodate a much larger volume of fluid. The resulting change in compliance alone is capable of producing edema in skin and skeletal muscle (65, 73) . This example illustrates a common difficulty in edema research-multiple mechanisms can lead to edema, and analytical tools are not able to determine their relative contributions.
Mathematical modeling provides a theoretical basis to interpret empirical
observations. Even though the equations governing interstitial inflow and outflow can be expressed algebraically, two complications arise when they are combined. First, interstitial fluid volume regulation results from classical negative feedback: any increase in interstitial volume acts to limit further increases in volume [unless tissue compliance becomes infinite (29) ]. Second, the principle of conservation of mass introduces a derivative (Eq. 4) into the equations that must be solved. To deal with these complications, investigators typically develop detailed mathematical models requiring numerical solutions (7, 8, 11, 33, 34, 64, 79) . Because results cannot be expressed analytically (i.e., by an algebraic formula), they must be expressed as separate plots of interstitial fluid volume as a function of any one of a long list of parameters and variables: microvascular pressure, plasma colloid osmotic pressure, water permeability, interstitial compliance, effective lymphatic resistance, venous pressure. Each resulting plot is only valid for a particular set of assumed parameters, limiting the generality of the results-each organ system, disease state, and pharmacological intervention must be simulated independently. Furthermore, the inability to view the effect of more than one parameter on interstitial fluid volume at any one time makes it impossible to grasp the complex interaction between microvascular filtration and lymphatic return. The purpose of the present work is therefore to present a simple, analytical formulation of Edemagenic Gain (the change in interstitial fluid volume resulting from changes in effective microvascular driving pressure) in terms of microvascular permeability, effective lymphatic resistance and interstitial compliance.
METHODS

Theory
The Starling-Landis Equation (Eq. 1) characterizes microvascular fluid filtration, relating the transmicrovascular water flow rate to an effective microvascular driving pressure (46, 58) . The difference between microvascular (P c ) and interstitial (P int ) hydrostatic pressures tends to force fluid into the interstitium. The difference between microvascular ( c ) and interstitial ( int ) colloid osmotic pressures tends to draw fluid in the opposite direction, from the interstitium into the microvessels. Unlike hydrostatic pressure, which is a force arising only from mechanical properties, oncotic pressure is a force that arises from physicochemical properties of solutions, and is proportional to the concentration of plasma proteins. The reflection coefficient ( ) characterizes the relative permeability of the microvasculature to plasma proteins (having a value between 0 and 1), and thus modulates the effective colloid osmotic pressure. The microvascular filtration coefficient (K f ) determines the amount of transmicrovascular fluid flow (J V ) that results from the net microvascular driving pressure gradient.
The value of K f depends on microvascular surface area and permeability to water.
The Drake-Laine Model (Eq. 2) characterizes lymphatic function by relating lymph flow rate (J L ) to an effective lymphatic driving pressure (15) . The difference in interstitial hydrostatic pressure (P int ) and systemic venous pressure (P sv ) tends to retard lymph flow, since P sv is typically greater than P int . The effective lymphatic resistance (R L ) is the slope of the relationship between net effective lymphatic driving pressure and the resulting lymph flow. The value of (P int +P p ) represents the effective lymphatic driving pressure composed of interstitial hydrostatic pressure and lymphatic pumping pressure (P p ).
( )
In this formulation, P p and R L are empirically-derived parameters used to describe the lymphatic pressure-flow relationship, and are not necessarily equivalent to pressure developed by lymphatic vessel contraction or resistance to lymph flow (15) .
Although the relationship of interstitial hydrostatic pressure and interstitial fluid volume is nonlinear (29, 66) , there is no widely accepted empirical model describing this relationship. A simple piecewise linear relationship between interstitial hydrostatic pressure (P int ) and interstitial fluid volume (V) is therefore assumed (Eq. 3). The slope of this relationship is the reciprocal of interstitial compliance (C),
where P o is an empirical constant. Typically, under normal conditions, interstitial fluid pressure is sensitive to changes in interstitial fluid volume (i.e., C is small). With overhydration, the compliance can become much larger, and the sensitivity of interstitial fluid pressure to interstitial fluid volume is lost. To capture this behavior, interstitial fluid pressure-volume relationship can be approximated to be "piecewise linear", a commonly used technique to deal with the effect of hydration on interstitial compliance (7, 11, 33 Table 1 .
Experiment
The experimental preparation has been described previously (25) . Experiments were This preparation allowed the measurement of pulmonary arterial (PAP) and left atrial pressures (LAP). A pressure control system was used to regulate the size of the left atrial balloon and control LAP in a subgroup of sheep (n = 5) (25) . Pulmonary microvascular pressure (P c ) was estimated as the average of PAP and LAP (25) . Solid-state pressure transducers, amplifiers and a chart recorder were used to record all pressures. We chose to use the olecranon as the zero pressure reference level because it is near the level of the left atrium and was easily identified (25) . Plasma colloid osmotic pressure ( c ) was measured with a membrane osmometer. Sheep were euthanized after a 3 h period and the extravascular fluid weight/blood free dry weight ratio (EVF) was determined utilizing a modification of the method of Pierce (25).
Control experiments.
We have previously determined the control relationship between EVF and P c c in the lungs of 9 anesthetized sheep (25) . In order to confirm the consistency of our experiments, we determined EVF in 2 additional control sheep. In the first experiment, EVF was 3.9 after a 3 h period with no elevation in microvascular pressure Histamine experiments. We infused 4 µg/kg/min of histamine phosphate into a total of nine sheep for a three hour period. In 7 sheep, histamine was infused into the systemic venous circulation, while in 2 other sheep it was infused into the pulmonary venous circulation. In five of these experiments, we used the pressure control system to control LAP so that P c was either 0 or 5 mmHg higher than c for the 3 h period. In four experiments, we did not elevate LAP. Two protocols for histamine infusion were used to evaluate whether different histamine infusion locations affect EVF with or without LAP elevation.
Analysis of previously reported data
Compliance estimation. To compare results of histamine infusion to increased systemic venous pressure, we analyzed data previously reported by Laine et al. (42) . Briefly, the effect of systemic venous pressure elevation on lung edema formation was determined by elevating superior vena caval pressure (SVCP) of anesthetized sheep (n = 8) by inflating a balloon occluder placed above the level of the azygos vein. Left atrial pressure was then controlled by partially inflating a balloon occluder inserted into the left atrium with and without elevating SVP to 10 mmHg for three hours. The amount of fluid present in the lung was determined from wet-to-dry weight ratios, similar to the current study.
Endotoxin infusion. Similarly, to compare results of histamine infusion to endotoxin infusion, we analyzed data previously reported by Gabel et al. (25) . Briefly, the effect of endotoxin infusion (1µg/kg) on lung edema formation was determined in anesthetized sheep (n = 6). LAP was varied by inflating a balloon occluder placed in left atrium. The amount of fluid present in the lung was determined from the wet-to-dry weight ratios, as in the current study. The resulting Edemagenic Gain for the endotoxin infusion group was compared to histamine and SVCP elevation groups.
RESULTS
Edemagenic Gain. Simultaneously solving Eqs. 1-4 and rearranging (See details in
Appendix) results in a ratio of V to (P cc ). We term this new equation "Edemagenic Gain" (EG).
Edemagenic Gain can be expressed in the form of a classical feedback system relating the tendency to store excess interstitial volume to the parameters C, R L , and K f . Edemagenic Gain is represented in the form of a "transfer function" relating an input variable, (P cc ), to an output variable, V (Fig. 1A) . The possible ranges of parameters derived from the literature are listed in Table 1 .
Compliance-Dominated and Multivariate gains. Equation 5 degenerates into an even
simpler form when the combination of R L ·K f is either much greater or less than 1.
When R L ·K f is much larger than 1, Edemagenic Gain is "Compliance-Dominated", and when R L ·K f is much less than 1, Edemagenic Gain is "Multivariate". Although K f is smaller than 1, R L can have fairly large values (see Table 1 ). Therefore, the value of R L ·K f is larger than 1 when R L is elevated, even if K f varies markedly. These results are summarized in Fig. 1B . Figure 2 illustrates the change in EVF plotted as a function of P c c for each experiment. The histamine EVFs were significantly higher than the control EVFs at baseline P c c and for P c c = 5 mmHg. The location of histamine infusion had no effect on EVF. In the two experiments with histamine infusion into the pulmonary venous circulation, EVFs were 4.7 without LAP elevation and 4.9 with LAP elevation. These EVFs were consistent with EVFs from the experiments with histamine infusion into the systemic venous circulation (with EVFs 4.5±0.2 without LAP elevation and 5.1±0.3 with LAP elevation). The estimate of Edemagenic Gain for the control group is 0.018 ml/g·mmHg, and 0.034 ml/g·mmHg subsequent to histamine infusion.
Effect of histamine.
Compliance estimation. Figure 3 illustrates the change in EVF resulting from a change in effective microvascular driving pressure in both control and the SVCP elevation groups. When LAP was elevated above control, a greater amount of pulmonary fluid accumulated in animals with elevated SVCP levels than the control group with normal SVCP. The estimate of Edemagenic Gain of the SVCP elevation group is 0.069 ml/g·mmHg, and that of the control group is 0.018 ml/g·mmHg. Assuming a high R L (Fig. 1B) , the interstitial compliance of the SVCP elevation group is therefore 0.069 ml/g·mmHg. Figure 3 illustrates the change in EVF in response to a change in effective microvascular driving pressure in the control case, as well as with histamine infusion, endotoxin infusion, and SVCP elevation.
Comparison between effects of histamine and endotoxin infusion.
Edemagenic Gain was the lowest in the control case (0.018 ml/g·mmHg). Edemagenic Gain of the endotoxin group (0.112 ml/g·mmHg) was greater than the histamine (0.04 ml/g·mmHg) and SVCP elevation groups (0.069 ml/g·mmHg).
DISCUSSION
We have developed a new concept, referred to as "Edemagenic Gain", relating changes in effective microvascular driving pressure to changes in interstitial fluid volume, and we related Edemagenic Gain to the three most important phenomena affecting fluid balance-microvascular filtration, lymphatic function, and interstitial fluid storage capacity (Eq. 5). By making simplifying assumptions, we were able to derive a simple algebraic formula for Edemagenic Gain. The resulting first-order approximation was rearranged to separate parameters characterizing structure (i.e., microvascular permeability, effective lymphatic resistance, and interstitial compliance) from input and output variables characterizing function (i.e., change in effective microvascular driving pressure and change in interstitial fluid volume). The resulting formulation presents the solution to classical fluid balance equations in a form recognizable as a classical negative feedback system (Fig. 1A) .
Thus, by accepting the cost of losing a degree of accuracy, we were able to reap the benefit of conceptual clarity that is not currently available from complex numerical simulations.
The concept of gain as an integrational approach to interstitial fluid dynamics.
Mathematically modeling the dynamics of interstitial fluid balance has had a long history, (7, 8, 11, 30, 33, 34, 64, 79) and resulted in concepts such an edema "safety factor" that have played a significant role in our current understanding of edema formation (31) . Typically, these approaches focused solely on hemodilution or hemorrhage, and the role of vascular permeability. Given how often the concepts of vascular permeability and interstitial compliance are invoked, it is perhaps overlooked that K f is a "black box" parameter relating hydrostatic and colloid osmotic pressure gradients to microvascular filtration and that C is a "black box" parameter relating interstitial fluid volume to pressure. The "black box" approach to interstitial fluid balance has further been refined K f , for instance, has been further reduced into smaller black boxes, such as "hydraulic conductivity" and "surface area" (50, 51) . The introduction of molecular biology analytical techniques has provided further opportunities to provide mechanistic interpretations, especially in the understanding of changes in interstitial compliance (63, 67) . Although this process of reductionism has led to fundamental new understanding of the individual physiological processes involved in edema formation and resolution, it has been unclear how these mechanistic elements interact with each other and thus affect interstitial fluid volume as a global variable, the necessary step to bridge basic science to clinically-relevant research. The approach used in the present work therefore provides an integrational approach that complements reductionist approaches, providing the means to 1) predict the implications of changes in any of the currently identified mechanistic elements on interstitial fluid volume, 2) determine the dominant mechanisms that have the greatest impact on interstitial fluid volume, 3) identify which parameters must first be determined before ascribing edema formation to any one process.
Our integrational approach is complementary to mechanistic studies, and in the present case, has at least identified what remains unknown and requires further study.
Necessary components to describe a physiological process as a gain. In order to derive an algebraic formula that characterizes a complex physiological process in terms of a constant "gain", it is necessary to formulate the system as 1) linear, 2) first-order, and 3) time-invariant (23, 41) . Even though most physiological processes are highly nonlinear, approximating them as linear is permissible when changes in the variables of interest are small. When variables change sufficiently to make nonlinear effects significant, it is common practice to treat the system as "piecewise linear". For example, the interstitial fluid pressurevolume relationship can be approximated as a combination of two linear relationships corresponding to two different levels of hydration (7, 11, 33) . Similarly, although most physiological processes can be overwhelmingly complex, approximating them as first-order (i.e., eliminating secondary effects) is permissible when the secondary effects are small. For instance, to arrive at the relationship between lymphatic driving pressure and lymph flow in alters one of these parameters, then the gain is said to have changed. Taken together, the assumptions that the system is linear, first-order, and time-invariant make it possible to avoid using a highly complex convection-diffusion transport model which must be solved numerically. Although numerical solutions can include many relevant details (7, 8, 11, 33, 34, 64, 79) , they cannot be expressed as a simple algebraic formula. In fact, such solutions can only be plotted graphically. Plotting volume as a function of just four parameters (K f , C, R L and ) cannot be accomplished in a single graph. Numerical solutions thus suffer from a loss of conceptual clarity, since they lack an explicit relationship of cause and effect, and require the knowledge of numerous variables that cannot be retrieved experimentally.
Reinterpreting the Lymphatic "Effective Resistance". The Drake-Laine lymphatic system model characterizes the lymphatic flow as a function of two lumped parameters: one describing the slope of the pressure-flow relationship and one describing the intercept. Using a convenient analogy to an electric circuit, these quantities have been referred as "effective lymphatic resistance" (R L ) and "lymphatic pump pressure" (P p ). Values for these parameters
have not yet been predicted from first principles, but are estimated from linear regression of measured data. They are therefore empirical (descriptive) parameters (15) . To date R L and P p have been used to describe lymphatic function in a number of organs (16, 18, 20, 43, 45) , but have yet to be assigned particular physiological interpretations. Much like K f , a "black box" parameter relating hydrostatic and colloid osmotic pressure gradients to microvascular filtration and C, a "black box" parameter relating interstitial fluid volume to pressure, R L and P p are similar "black box" parameters which relate lymphatic outflow to interstitial fluid pressure. Since transserosal flow, flow across the serous membrane which encloses several organs, is ultimately collected by lymphatics and returned to systemic circulation, transserosal flow is accommodated by the Drake-Laine model. The historical use of the term "effective resistance" to describe the empirically-derived slope of the line of the pressure gradient-flow relationship is unfortunate and has caused some consternation, since this empirical relationship clearly arises from an active pumping of lymph, rather than a purely passive process as implied by the term "resistance" (3).
Edemagenic Gain suggests a novel structure-based classification of edema.
The equation used in the present work to approximate Edemagenic Gain (Eq. 5) assumes an even simpler form (Eq. 6) when specific parameters are either very large or small. In the first case, when effective lymphatic resistance is significantly elevated, R L ·K F can become much larger than 1. The value of 1+R L ·K F thus becomes approximately equal to R L ·K F and EG can be approximated by C. Under such conditions, interstitial compliance alone determines Edemagenic Gain and thus the susceptibility to edema, irrespective of the particular value of the microvascular filtration coefficient (Fig. 1B) . In other words, Edemagenic Gain becomes "Compliance-Dominated". In most other cases, however, R L is relatively small, including edema caused by enhanced microvascular permeability. Edemagenic Gain then depends on the combination of interstitial compliance (C), effective lymphatic resistance (R L ), and microvascular permeability (K f ) (Fig. 1B) . In this case, Edemagenic Gain is "Multivariate". This analysis has therefore revealed two types of gain; "Compliance-Dominated" approximately equal to C and "Multivariate" dependent on C, R L , and K f . In both cases, interstitial compliance plays a significant role in edema formation. This structure-based classification of edema provides a novel approach to estimate interstitial compliance on one hand, and a novel insight into the causes of edema on the other.
Edemagenic Gain provides a novel approach to estimate interstitial compliance.
Conventional techniques to estimate interstitial compliance require recording changes in both interstitial fluid volume and interstitial hydrostatic pressure. Whereas methods to measure changes in tissue fluid volume are fairly accurate and stable, measuring interstitial hydrostatic pressure is problematic. Wiig et al. reported significant deviation when comparing interstitial hydrostatic pressure measurements derived from micropipette techniques, chronic perforated and porous capsule techniques, and wick methods (72) (73) (74) (75) .
The concept of Edemagenic Gain provides an alternative approach that eliminates the need to measure interstitial fluid pressure. By increasing effective lymphatic resistance (or alternatively increasing lymphatic outflow pressure), Edemagenic Gain becomes equal to interstitial compliance (C) (Eq. 6). Only changes in interstitial fluid volume and microvascular hydrostatic pressure therefore must be measured to estimate C. This method can be particularly useful to determine chronic changes in tissue compliance, especially in the myocardium and lungs where interstitial fluid pressure measurement is confounded by tissue motion (54) . Indeed, since the edema in the SVCP elevation group described in Fig. 3 was caused by an intervention that decreased lymphatic flow (comparable to impaired outflow edema), Edemagenic Gain is expected to depend only on the interstitial compliance (Fig. 1B) . Interstitial compliance estimated using our novel method (C = 0.069 ml/g·mmHg) is within the range previously estimated by conventional methods (Table 1) .
Edemagenic Gain provides a novel insight into the causes of edema.
Determining how a physiologic intervention causes edema is particularly difficult, because it is not possible to directly measure microvascular permeability, effective lymphatic resistance, and interstitial compliance in a single experiment. The present work uses the example of histamine-induced edema to illustrate how the concept of Edemagenic Gain can reconcile disparate reports. First, several reports suggest that increases in the microvascular filtration coefficient are responsible for histamine-induced edema (6, 40, 49, 56, 60) . Second, inhibition of lymph flow by histamine (22, 62) , suggests changes in lymphatic function could be responsible for histamine-induced edema. Third, interstitial fluid pressure measurement studies have demonstrated that interstitial compliance increases significantly after histamine infusion, suggesting changes in compliance alone may be responsible for histamine-induced edema, as it is for edema induced by other inflammatory agents (2, 4, 5, 27, 37-39, 57, 65, 69, 77) . From an experimental standpoint, our results (slope, Fig. 2 ) clearly indicate that histamine increases Edemagenic Gain by approximately a factor of two. However, our theoretical formulation (Eq. 5) suggests that all three parameters C, R L , and K f may determine the extent of edema formation. In this case, there is not enough information contained in the data to exclude any of the three postulated edemagenic mechanisms.
Active Regulation of C, R L , and K f . Until recently, interstitial compliance and effective lymphatic resistance were considered as passive properties (29, 31) . Recent studies, however, have suggested that these properties are actively regulated. Effective lymphatic resistance, for instance, has been shown to be a regulated property, since it is affected by several neurohormonal factors that modulate lymphatic function (21, 22, 35, 36, 62, 70) .
Furthermore recent studies have suggested that interstitial compliance is not only passively affected by the level of hydration, but also by modulation of U1-integrin adhesions (39, 63, 67, 76, 78) . The present work presents a framework to study the effect of acute to chronic regulation of the structural properties C, R L , and K f . Not only can the Edemagenic Gain be used to identify changes in critical properties that produce edema, such as permeability, it can conversely identify structural changes resulting from edema, such as changes in interstitial compliance following fibrosis. not determined in the present study, although there is evidence that histamine and endotoxin decrease and may increase int (10, 25, 49, 60) . To take advantage of measurements of and int in future studies, Edemagenic Gain could be reformulated (see Appendix) such that and int are variables (Eq. A6). In this case, the Edemagenic Gain is expressed as V/ (P c -( c int )). Not only can this more general formulation incorporate changes in or int , it can capture such phenomena as "protein washdown". This more general formulation degenerates into V/ (P cc ), as in Eq. 5, when variables and int are constant. If all the parameters change (e.g., P c , c , int and ) with a particular intervention, then they would all need to be independently measured. The measurement of and int would allow more accurate estimation of the Edemagenic Gain. The process of simplification used in the present work could therefore be used as a guide for investigators developing new approximations of Edemagenic Gain. Caution is advised, however, a previous attempt to relate interstitial volume to effective microvascular driving pressures (25) oversimplified the equations, and the critical contribution of interstitial compliance was neglected (see Appendix).
Generalizing Edemagenic Gain
Extrapolation of Edemagenic Gain estimations to different organs. The Edemagenic
Gain formulation is general-no assumptions of a specific organ or parameter values were necessary to define EG in Eq. 5. To use the Edemagenic Gain formulation for a specific organ, the model should be evaluated and validated with particular attention to the specific assumptions made for the organ under study. In the present study, for instance, values of C, R L and K f listed in Table 1 are used to characterize interstitial fluid balance in lung. The lung model has been well-studied over the last four decades, and the measurements for all three parameters (C, R L , and K f ) have been determined (Table 1) . A dilemma may arise, however, when extrapolating the outcomes to other organ systems, especially those for which the measurements of the parameters are not available. In this case, either the unknown parameters must be determined before predicting the Edemagenic Gain, or the ranges of the permissible values of the parameters should be determined to estimate the range of Edemagenic Gain that can result. The sensitivity analysis presented in Table 2 provides some guidance to determine how critical a particular parameter value is. In some specific cases (such as when the Edemagenic Gain is "Compliance-Dominated"), the particular values of parameters (such as R L and K f ) have a relatively small influence. Extrapolation of the present model implementation to other organ systems must be evaluated on a case-by-case basis.
Inflammatory agents have disparate effects on Edemagenic Gain. The concept of
Edemagenic Gain can be used to characterize the extent to which specific inflammatory agents can sensitize tissues to edemagenic conditions. Both histamine and endotoxin are proinflammatory agents that can result in similar degrees of edema. However, pulmonary edema induced by endotoxin does not regress, even after significant reduction in effective lymphatic resistance (44) . Analysis presented in Fig. 4 ( )
By substituting Eq. A1 and the Drake-Laine Model (Eq. 3), into Eq. 4, the effect of changes in interstitial fluid volume on lymphatic flow can be reformulated into an integral,
where V o is the initial volume.
Integrating Eq. A2 results in interstitial fluid volume as an analytical equation that includes a function of time (t).
Assuming all parameters are constant, the difference between two volumes is obtained as a result of changes in effective microvascular driving pressure (P cc ) and expressed as "Edemagenic Gain" (Eq. 5)
In previous attempts to characterize the change in interstitial fluid volume in response to change in the effective microvascular driving pressure (25) , interstitial hydrostatic pressure was considered constant. The negative feedback provided by changes in interstitial hydrostatic pressure, therefore, was neglected. The change in interstitial fluid volume given by the time integral of the inflow and outflow rate (Eq. 4) would thus be ( )
The relation between change in interstitial fluid volume and change in effective microvascular driving pressure is obtained from Eq. A4.
The formulation of Edemagenic Gain presented in the current work (Eq. 5) is preferred over
Eq. A5, because Eq. 5 does not require the assumption that interstitial hydrostatic pressure is constant, and thus it requires fewer assumptions.
The formulation of Edemagenic Gain represented by Eq. 5 can be modified to characterize the relationship of V to changes in the microvascular driving pressure determined by P c , c , int , and . The modified Edemagenic Gain thus becomes a function of the microvascular reflection coefficient, as well as interstitial colloid osmotic pressure Edemagenic Gains of the three intervention groups are larger than that of the control group (0.018 ml/g·mmHg). The endotoxin group (0.112 ml/g·mmHg) has larger Edemagenic Gain compared to the histamine group (0.134 ml/g·mmHg) and SVCP elevation group (0.069 ml/g·mmHg). ) is significantly elevated (as in the case of impaired outflow edema), only interstitial compliance (C) determines Edemagenic Gain. In other cases, including enhanced inflow edema (as in the case of increased microvascular filtration), all three parameters, interstitial compliance (C), effective lymphatic resistance (R L ), and microvascular filtration coefficient (K f ) determine Edemagenic Gain. 
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